Stock Scorecard
Stock Summary for Indivior Plc (INDV) - $35.12 as of 12/8/2025 3:36:42 PM EST
Total Score
15 out of 30
Safety Score
54 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for INDV
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for INDV
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for INDV
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for INDV
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for INDV (54 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 6 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 4 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for INDV
Financial Details for INDV
Company Overview |
|
|---|---|
| Ticker | INDV |
| Company Name | Indivior Plc |
| Country | USA |
| Description | Indivior PLC is a leading biopharmaceutical company headquartered in North Chesterfield, Virginia, focused on developing innovative treatments for opioid dependence and related disorders. Known for its pioneering work with buprenorphine-based therapies, Indivior aims to improve patient outcomes and tackle the complexities associated with opioid use disorder. The company demonstrates a strong commitment to public health through substantial investments in research and development, reinforcing its position as a transformative leader in addiction treatment. With a comprehensive product portfolio and a dedicated patient-centric approach, Indivior is well-prepared to address the evolving challenges within the healthcare landscape. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/12/2026 |
Stock Price History |
|
| Last Day Price | 35.12 |
| Price 4 Years Ago | 17.25 |
| Last Day Price Updated | 12/8/2025 3:36:42 PM EST |
| Last Day Volume | 8,288,771 |
| Average Daily Volume | 2,434,133 |
| 52-Week High | 38.00 |
| 52-Week Low | 7.62 |
| Last Price to 52 Week Low | 360.89% |
Valuation Measures |
|
| Trailing PE | 35.84 |
| Industry PE | 83.75 |
| Sector PE | 89.35 |
| 5-Year Average PE | -26.51 |
| Free Cash Flow Ratio | 9.87 |
| Industry Free Cash Flow Ratio | 12.32 |
| Sector Free Cash Flow Ratio | 28.79 |
| Current Ratio Most Recent Quarter | 0.96 |
| Total Cash Per Share | 3.56 |
| Book Value Per Share Most Recent Quarter | -1.66 |
| Price to Book Ratio | 145.25 |
| Industry Price to Book Ratio | 10.27 |
| Sector Price to Book Ratio | 33.16 |
| Price to Sales Ratio Twelve Trailing Months | 3.72 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.66 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.82 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 125,024,000 |
| Market Capitalization | 4,390,842,880 |
| Institutional Ownership | 81.49% |
Dividends |
|
| Ex-Dividend Date | 6/16/2016 |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.4750 |
| Total Years Dividend Increasing | 2 |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 2.31 |
| Forward Annual Dividend Yield | 19.85% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 100.00% |
| 3-Year Dividend Growth Rate Percentage | 143.67% |
| 5-Year Dividend Growth Rate Percentage | 143.67% |
| All-Time Dividend Growth Rate Percentage | 196.88% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 106.30% |
| Annual Earnings Growth | 101.55% |
| Reported EPS 12 Trailing Months | 0.98 |
| Reported EPS Past Year | 1.64 |
| Reported EPS Prior Year | -0.07 |
| Net Income Twelve Trailing Months | 166,000,000 |
| Net Income Past Year | 2,000,000 |
| Net Income Prior Year | -129,000,000 |
| Quarterly Revenue Growth YOY | 2.30% |
| 5-Year Revenue Growth | 8.64% |
| Operating Margin Twelve Trailing Months | 36.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 445,000,000 |
| Total Cash Past Year | 319,000,000 |
| Total Cash Prior Year | 316,000,000 |
| Net Cash Position Most Recent Quarter | 141,000,000 |
| Net Cash Position Past Year | 4,000,000 |
| Long Term Debt Past Year | 315,000,000 |
| Long Term Debt Prior Year | 236,000,000 |
| Total Debt Most Recent Quarter | 304,000,000 |
| Equity to Debt Ratio Past Year | 0.00 |
| Equity to Debt Ratio Most Recent Quarter | -2.13 |
| Total Stockholder Equity Past Year | -348,000,000 |
| Total Stockholder Equity Prior Year | -191,000,000 |
| Total Stockholder Equity Most Recent Quarter | -207,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 134,981,961 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.08 |
| Free Cash Flow Past Year | 7,000,000 |
| Free Cash Flow Prior Year | -353,000,000 |
Options |
|
| Put/Call Ratio | 1.08 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.67 |
| MACD Signal | 1.70 |
| 20-Day Bollinger Lower Band | 16.74 |
| 20-Day Bollinger Middle Band | 25.78 |
| 20-Day Bollinger Upper Band | 34.82 |
| Beta | 1.11 |
| RSI | 67.46 |
| 50-Day SMA | 16.85 |
| 150-Day SMA | 17.18 |
| 200-Day SMA | 17.59 |
System |
|
| Modified | 12/9/2025 2:17:53 AM EST |